Graves' Ophthalmopathy

15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

FORMAN, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858 · see citing works

Adipocyte differentiation from the inside out

Rosen, E. D., & MacDougald, O. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2066 · Cited by 2,607 · see citing works

Obesity-induced inflammatory changes in adipose tissue

Wellen, K. E., & Hotamisligil, G. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320514 · Cited by 1,823 · see citing works

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Smolen, J. S., Beaulieu, A. D., Rubbert‐Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., WOODWORTH, T. G., & Alten, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60453-5 · Cited by 1,399 · see citing works

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099 · see citing works

Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA4Ig

Kremer, J. M., Westhovens, R., Leon, M., Giorgio, E. D., Alten, R., Steinfeld, S. D., RUSSELL, A. S., Dougados, M., Emery, P., Nuamah, I. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035075 · Cited by 1,053 · see citing works

Emerging roles of PPARS in inflammation and immunity

Daynes, R. A., & Jones, D. C. (2002) · Nature reviews. Immunology · doi:10.1038/nri912 · Cited by 922 · see citing works

Management of Graves' Ophthalmopathy: Reality and Perspectives

Bartalena, L., Pinchera, A., & Marcocci, C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0393 · Cited by 673 · see citing works

Development of anti-TNF therapy for rheumatoid arthritis

Feldmann, M. (2002) · Nature reviews. Immunology · doi:10.1038/nri802 · Cited by 667 · see citing works

Interleukin 6: from bench to bedside

Nishimoto, N., & Kishimoto, T. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0338 · Cited by 639 · see citing works

New Drugs for Rheumatoid Arthritis

Olsen, N. J., & Stein, C. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032906 · Cited by 632 · see citing works

Pathogenesis of Graves' Ophthalmopathy

Epstein, F. H., Bahn, R. S., & Heufelder, A. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292007 · Cited by 610 · see citing works

TGF-β and fibrosis in different organs — molecular pathway imprints

Pohlers, D., Brenmoehl, J., Loeffler, I., Müller, C. K., Leipner, C., Schultze–Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576 · see citing works

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

Straus, D. S., & Glass, C. K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.003 · Cited by 553 · see citing works

Molecular Cloning of the Thyrotropin Receptor

Parmentier, M., Libert, F., Maenhaut, C., Lefort, A., Gerard, C. M., Perret, J., SANDE, J. V., Dumont, J. E., & Vassart, G. (1989) · Science · doi:10.1126/science.2556796 · Cited by 527 · see citing works

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

Nagayama, Y., Kaufman, K. D., Seto, P., & Rapoport, B. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92727-7 · Cited by 520 · see citing works

B-cell targeting in rheumatoid arthritis and other autoimmune diseases

Edwards, J., & Cambridge, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1838 · Cited by 508 · see citing works

Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy

Prabhakar, B. S., Bahn, R. S., & Smith, T. J. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0020 · Cited by 489 · see citing works

Thyrotropin Receptor Autoantibodies Are Independent Risk Factors for Graves’ Ophthalmopathy and Help to Predict Severity and Outcome of the Disease

Eckstein, A. K., Plicht, M., Lax, H., Neuhäuser, M., Mann, K., Lederbogen, S., Heckmann, C., Esser, J., & Morgenthaler, N. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2813 · Cited by 477 · see citing works

Smoking and Risk of Graves' Disease

Prummel, M. F. (1993) · JAMA · doi:10.1001/jama.1993.03500040045034 · Cited by 464 · see citing works

Epidemiology and Prevention of Graves' Ophthalmopathy

Wiersinga, W. M., & Bartalena, L. (2002) · Thyroid · doi:10.1089/105072502761016476 · Cited by 454 · see citing works

The Role of CD40 Ligand in Costimulation and T‐Cell Activation

Grewal, I. S., & Flavell, R. A. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00921.x · Cited by 450 · see citing works

Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy

Bartalena, L., Baldeschi, L., Dickinson, A. J., Eckstein, A., Kendall-Taylor, P., Marcocci, C., Mourits, M. P., Perros, P., Boboridis, K., Boschi, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0315 · Cited by 406 · see citing works

Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and Results in Clinical Improvement in a Patient with Pretibial Myxedema

Menzinger, S., Kaya, A., Saurat, J. ‐., & Kaya, G. (2016) · Dermatopathology · doi:10.1159/000446699 · Cited by 398 · see citing works

A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in Vitro

Nordan, R. P., & Potter, M. (1986) · Science · doi:10.1126/science.3726549 · Cited by 375 · see citing works

The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1

Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373 · see citing works

Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ Disease

Tsui, S., Naik, V. M., Hoa, N. T., Hwang, C. J., Afifiyan, N. F., Hikim, A. P. S., Gianoukakis, A. G., Douglas, R. S., & Smith, T. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4397 · Cited by 371 · see citing works

The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Bartley, G. B. (1994) · PubMed Central · Cited by 354 · see citing works

Anakinra for Rheumatoid Arthritis: A Systematic Review

Mertens, M. T., & Singh, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 342 · see citing works

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti‐CD154: A randomized, double‐blind, placebo‐controlled trial

KALUNIAN, K. C., Davis, J. C., Merrill, J. T., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10681 · Cited by 337 · see citing works

Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy

Gerding, M. N., Meer, J. W. C. V. D., Broenink, M., Bakker, O., Wiersinga, W. M., & Prummel, M. F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00959.x · Cited by 325 · see citing works

Connective Tissue, Glycosaminoglycans, and Diseases the Thyroid*

Smith, T. J., Bahn, R. S., & Gorman, C. A. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-366 · Cited by 320 · see citing works

Immunoglobulin Activation of T Cell Chemoattractant Expression in Fibroblasts from Patients with Graves’ Disease Is Mediated Through the Insulin-Like Growth Factor I Receptor Pathway

Pritchard, J., Han, R., Horst, N., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6348 · Cited by 297 · see citing works

Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue

Feliciello, A., Ciullo, I., Fenzi, G., Bonavolontà, G., Porcellini, A., & Avvedimento, E. V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91475-2 · Cited by 287 · see citing works

Design of effective immunotherapy for human autoimmunity

Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 277 · see citing works

Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes

Koumas, L., Smith, T. J., Feldon, S. E., Blumberg, N., & Phipps, R. P. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63488-8 · Cited by 277 · see citing works

Treatment of Graves’ disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study

Salvi, M., Vannucchi, G. M., Campi, I., Currò, N., Dazzi, D., Simonetta, S., Bonara, P., Rossi, S., Sina, C., Guastella, C., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02325 · Cited by 262 · see citing works

Management of Graves' Ophthalmopathy: Reality and Perspectives

Bartalena, L. (2000) · Endocrine Reviews · doi:10.1210/er.21.2.168 · Cited by 257 · see citing works

Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology

Knouff, C., & Auwerx, J. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0036 · Cited by 256 · see citing works

Immunoglobulins from Patients with Graves’ Disease Induce Hyaluronan Synthesis in Their Orbital Fibroblasts through the Self-Antigen, Insulin-Like Growth Factor-I Receptor

Smith, T. J., & Hoa, N. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0716 · Cited by 256 · see citing works

Cigarette smoking and autoimmune disease: what can we learn from epidemiology?

Costenbader, K. H., & Karlson, E. W. (2006) · Lupus · doi:10.1177/0961203306069344 · Cited by 237 · see citing works

Pathophysiology of Graves’ Ophthalmopathy: The Cycle of Disease

Bahn, R. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030010 · Cited by 231 · see citing works

Thyrotropin Receptor Expression in Graves’ Orbital Adipose/Connective Tissues: Potential Autoantigen in Graves’ Ophthalmopathy1

Bahn, R. S., Dutton, C. M., Natt, N., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4676 · Cited by 228 · see citing works

TSH‐R expression and cytokine profile in orbital tissue of active vs. inactive Graves’ ophthalmopathy patients

Wakelkamp, I. M. M. J., Bakker, O., Baldeschi, L., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01708.x · Cited by 223 · see citing works

Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy

Smith, T. J., Koumas, L., Gagnon, A.-M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8164 · Cited by 210 · see citing works

Pretibial Myxedema

Fatourechi, V. (2005) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200506050-00003 · Cited by 209 · see citing works

Thyrotropin Receptor Expression in Graves' Orbital Adipose/Connective Tissues: Potential Autoantigen in Graves' Ophthalmopathy

Bahn, R. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.998 · Cited by 201 · see citing works

Smoking and Thyroid-Associated Ophthalmopathy: A Novel Explanation of the Biological Link

Cawood, T., Moriarty, P., O’Farrelly, C., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1824 · Cited by 200 · see citing works

The effect of etanercept on Graves' ophthalmopathy: a pilot study

Paridaens, D. A., van den Bosch, W. A., Tl, V. D. L., Krenning, E. P., & van Hagen, P. M. (2004) · Eye · doi:10.1038/sj.eye.6701768 · Cited by 192 · see citing works

Appearance of Gravesʼ Disease on Orbital Computed Tomography

Enzmann, D. R., Donaldson, S. S., & Kriss, J. P. (1979) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-197903060-00019 · Cited by 185 · see citing works

Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy*

Hiromatsu, Y., Yang, D., Bednarczuk, T., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6433 · Cited by 184 · see citing works

Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture

Sorisky, A., Pardasani, D., Gagnon, A., & Smith, T. J. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784110 · Cited by 180 · see citing works

Differentiation of Human Orbital Preadipocyte Fibroblasts Induces Expression of Functional Thyrotropin Receptor1

Valyasevi, R. W., Erickson, D. Z., Harteneck, D. A., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5838 · Cited by 173 · see citing works

Detection of TSH Receptor RNA in Cultured Fibroblasts from Patients with Graves' Ophthalmopathy and Pretibial Dermopathy

Heufelder, A. E., Dutton, C. M., Sarkar, G., et al. (1993) · Thyroid · doi:10.1089/thy.1993.3.297 · Cited by 170 · see citing works

Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle.

Forbes, G. S., Gorman, C. A., BRENNAN, M. D., et al. (1986) · PubMed · Cited by 168 · see citing works

Characterization of Thyrotropin Receptor Antibody-Induced Signaling Cascades

MORSHED, S. A., Latif, R., & Davies, T. F. (2008) · Endocrinology · doi:10.1210/en.2008-0878 · Cited by 165 · see citing works

Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production

Sempowski, G. D., Rozenblit, J., Smith, T. J., & Phipps, R. P. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.3.c707 · Cited by 162 · see citing works

Dysthyroid Ocular Myopathy

Kroll, A. J. (1966) · Archives of Ophthalmology · doi:10.1001/archopht.1966.03850010246017 · Cited by 154 · see citing works

Temporal relationship between onset of Graves’ ophthalmopathy and onset of thyroidal Graves’ disease

Wiersinga, W. M., Smit, T. J., van der Gaag, R. D., & Koornneef, L. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350193 · Cited by 150 · see citing works

The Thyrotropin Receptor in Graves' Disease

Rapoport, B., & McLachlan, S. M. (2007) · Thyroid · doi:10.1089/thy.2007.0170 · Cited by 143 · see citing works

Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy

Eckstein, A. K., Lösch, C., Glowacka, D., et al. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.137265 · Cited by 142 · see citing works

Graves' Ophthalmopathy in the Absence of Elevated Free Thyroxine and Triiodothyronine Levels: Prevalence, Natural History, and Thyrotropin Receptor Antibody Levels

Khoo, D. H. C., Eng, P., Ho, S.-C., Tai, E. S., Morgenthaler, N. G., Seah, L. L., Fong, K. S., Chee, S.-P., Choo, C. T., & Aw, S. E. (2000) · Thyroid · doi:10.1089/thy.2000.10.1093 · Cited by 138 · see citing works

Relationship between Disease Duration and Predominant Orbital T Cell Subset in Graves’ Ophthalmopathy

Aniszewski, J. P., Valyasevi, R. W., & Bahn, R. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6333 · Cited by 136 · see citing works

Thyrotropin Receptor Transcripts in Human Adipose Tissue

Crisp, M., Lane, C., Halliwell, M., Wynford‐Thomas, D., & Ludgate, M. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.2003 · Cited by 134 · see citing works

Elephantiasic Pretibial Myxedema: Insight into and a Hypothesis Regarding the Pathogenesis of the Extrathyroidal Manifestations of Graves' Disease

Rapoport, B., Alsabeh, R., Aftergood, D., & McLachlan, S. M. (2000) · Thyroid · doi:10.1089/10507250050137761 · Cited by 130 · see citing works

Insight into Graves’ Hyperthyroidism from Animal Models

McLachlan, S. M., Nagayama, Y., & Rapoport, B. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0023 · Cited by 129 · see citing works

Stimulation of Adipogenesis, Peroxisome Proliferator-Activated Receptor-γ (PPARγ), and Thyrotropin Receptor by PPARγ Agonist in Human Orbital Preadipocyte Fibroblasts

Valyasevi, R. W., Harteneck, D. A., Dutton, C. M., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8472 · Cited by 129 · see citing works

Clinical Presentation of Graves’ Ophthalmopathy

Wiersinga, W. M., Smit, T. J., van der Gaag, R., et al. (2009) · Ophthalmic Research · doi:10.1159/000266782 · Cited by 120 · see citing works

Long-term effects of Graves' ophthalmopathy on health-related quality of life.

Terwee, C., Wakelkamp, I., Tan, S. H., Dekker, F., Prummel, M., & Wiersinga, W. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460751 · Cited by 120 · see citing works

Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts

Smith, T. J., Wang, H. S., & Evans, C. H. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.2.c382 · Cited by 118 · see citing works

Autologous T-Lymphocytes Stimulate Proliferation of Orbital Fibroblasts Derived from Patients with Graves’ Ophthalmopathy

Feldon, S. E., Park, D. J. J., O’Loughlin, C. W., et al. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0605 · Cited by 117 · see citing works

Retrobulbar pressures measured during surgical decompression of the orbit.

Otto, A. J., Koornneef, L., Mourits, M. P., et al. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.12.1042 · Cited by 116 · see citing works

Treatment-Resistant Severe, Active Graves' Ophthalmopathy Successfully Treated with B Lymphocyte Depletion

Fassi, D. E., Nielsen, C. H., Hasselbalch, H. C., & Hegedűs, L. D. (2006) · Thyroid · doi:10.1089/thy.2006.16.709 · Cited by 116 · see citing works

Infliximab: A Novel Treatment for Sight-Threatening Thyroid Associated Ophthalmopathy

Durrani, O. M., Reuser, T. Q., & Murray, P. I. (2005) · Orbit · doi:10.1080/01676830590912562 · Cited by 111 · see citing works

Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated Ophthalmopathy

Smith, T. J., Tsai, C., Shih, M.-J., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0404 · Cited by 108 · see citing works

Leukoregulin Induction of Prostaglandin-Endoperoxide H Synthase-2 in Human Orbital Fibroblasts

Wang, H.-S., Cao, H., Winn, V. D., Rezanka, L. J., Frobert, Y., Evans, C. H., Sciaky, D., Young, D. A., & Smith, T. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22718 · Cited by 108 · see citing works

Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to Adipocytes

Feldon, S. E., O’Loughlin, C. W., Ray, D. M., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060434 · Cited by 100 · see citing works

A Low-Molecular-Weight Antagonist for the Human Thyrotropin Receptor with Therapeutic Potential for Hyperthyroidism

Neumann, S., Kleinau, G., Costanzi, S., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0836 · Cited by 100 · see citing works

Smoking and risk of Graves' disease

Prummel, M. F. (1993) · JAMA · doi:10.1001/jama.269.4.479 · Cited by 100 · see citing works

Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts.

Jm, K., Loftus, S. J., & Bahn, R. S. (1992) · PubMed · Cited by 99 · see citing works

Clinical Utility of Thyrotropin-Receptor Antibody Assays: Comparison of Radioreceptor and Bioassay Methods

MORRIS, J. C., HAY, I. D., NELSON, R. E., & Jiang, N. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65533-5 · Cited by 97 · see citing works

Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies

Fassi, D. E., Banga, J. P., Gilbert, J. A., Padoa, C. J., Hegedűs, L. D., & Nielsen, C. H. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.09.007 · Cited by 92 · see citing works

Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo

Starkey, K., Janezić, A., Jones, G., et al. (2003) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0300369 · Cited by 90 · see citing works

Peroxisome Proliferator-Activated Receptor-γ in Thyroid Eye Disease: Contraindication for Thiazolidinedione Use?

Starkey, K. J., Heufelder, A. E., Baker, G. R. C., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020987 · Cited by 89 · see citing works

Graves Ophthalmopathy: The Bony Orbit in Optic Neuropathy, Its Apical Angular Capacity, and Impact on Prediction of Risk

Chan, L. L., Tan, H.-E., Fook-Chong, S. M. C., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1413 · Cited by 89 · see citing works

Relative Overexpression of Macrophage-Derived Cytokines in Orbital Adipose Tissue from Patients with Graves’ Ophthalmopathy

Kumar, S., & Bahn, R. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030380 · Cited by 89 · see citing works

Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts

Zhang, L., Bowen, T., Grennan-Jones, F., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.003616 · Cited by 84 · see citing works

Biological Effects of Thyrotropin Receptor Activation on Human Orbital Preadipocytes

Zhang, L., Baker, G. R. C., Januś, D., et al. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0596 · Cited by 84 · see citing works

Susceptibility genes in Graves’ ophthalmopathy: searching for a needle in a haystack?

Bednarczuk, T., Gopinath, B., Płoski, R., & Wall, J. R. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02854.x · Cited by 83 · see citing works

Dysthyroid Optic Neuropathy Without Extraocular Muscle Involvement

Anderson, R. L., Tweeten, J. P., Patrinely, J. R., Garland, P. E., & Thiese, S. M. (1989) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/1542-8877-19890801-09 · Cited by 83 · see citing works

Differentiation of Human Orbital Preadipocyte Fibroblasts Induces Expression of Functional Thyrotropin Receptor

Valyasevi, R. W. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2557 · Cited by 82 · see citing works

B Cells, Be Gone — B-Cell Depletion in the Treatment of Rheumatoid Arthritis

Tsokos, G. C. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048114 · Cited by 79 · see citing works

TSH receptor gene expression in retroocular fibroblasts

Mengistu, M. E., Lukes, Y. G., Nagy, E. V., Burch, H. B., Carr, F. E., LAHIRI, S., & Burman, K. D. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347732 · Cited by 77 · see citing works

Thyrotropin Receptor Expression in Adrenal, Kidney, and Thymus

Dutton, C. M., Joba, W., Spitzweg, C., et al. (1997) · Thyroid · doi:10.1089/thy.1997.7.879 · Cited by 75 · see citing works

Cytokine Profiles in Eye Muscle Tissue and Orbital Fat Tissue from Patients with Thyroid-Associated Ophthalmopathy

Hiromatsu, Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1194 · Cited by 75 · see citing works

Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes

Davies, T. F., TENG, C. S., McLachlan, S. M., et al. (1978) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(78)90072-2 · Cited by 74 · see citing works

Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO)

Pappa, A., Calder, V. L., Ajjan, R., Fells, P., Ludgate, M. E., Weetman, A. P., & Lightman, S. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.4491347.x · Cited by 74 · see citing works

Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy.

Tan, G. H., Dutton, C. M., & Bahn, R. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.2.8636247 · Cited by 73 · see citing works

Serum Selenium Levels in Patients with Remission and Relapse of Graves Disease

Wertenbruch, T., Willenberg, H. S., Sagert, C., Nguyen, T.-B.-T., Pavlicek‐Bahlo, M., Feldkamp, J., Groeger, C., Hermsen, D. F., Scherbaum, W. A., & Schott, M. (2007) · Medicinal Chemistry · doi:10.2174/157340607780620662 · Cited by 71 · see citing works

Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy

Daumerie, C., Ludgate, M. E., Costagliola, S., et al. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460035 · Cited by 70 · see citing works

Overexpression of Immediate Early Genes in Active Graves’ Ophthalmopathy

Lantz, M., Vondrichova, T., Parikh, H. M., Frenander, C., Ridderstråle, M., Åsman, P., Åberg, M., Groop, L., & Hallengren, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2275 · Cited by 68 · see citing works

Gene Expression Profiling of Orbital Adipose Tissue from Patients with Graves’ Ophthalmopathy: A Potential Role for Secreted Frizzled-Related Protein-1 in Orbital Adipogenesis

Kumar, S., Leontovich, A. A., Coenen, M. J., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2239 · Cited by 68 · see citing works

Thyrotropin Receptor in Non-thyroid Tissues

Endo, T., Ohno, M., Kotani, S., et al. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1116 · Cited by 68 · see citing works

Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues.

Paschke, R., Metcalfe, A., Alcalde, L., et al. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962314 · Cited by 67 · see citing works

The Putative Role of Fibroblasts in the Pathogenesis of Graves' Disease: Evidence for the Involvement of the Insulin-like Growth Factor-1 Receptor in Fibroblast Activation

Smith, T. J. (2003) · Autoimmunity · doi:10.1080/08916930310001603000 · Cited by 65 · see citing works

Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.

Otto, E. A., Ochs, K., Hansen, C., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768872 · Cited by 64 · see citing works

Effect of Tumor Necrosis Factor-α, Interferon-γ, and Transforming Growth Factor-β on Adipogenesis and Expression of Thyrotropin Receptor in Human Orbital Preadipocyte Fibroblasts1

Valyasevi, R. W., Jyonouchi, S. C., Dutton, C. M., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7188 · Cited by 60 · see citing works

Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: Effects on orbital lymphocytic infiltrates

Salvi, M., Vannucchi, G. M., Campi, I., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.005 · Cited by 58 · see citing works

Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated Ophthalmopathy

Smith, T. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.385 · Cited by 58 · see citing works

PRESENT CONCEPTS OF THE PATHOLOGIC PHYSIOLOGY OF EXOPHTHALMOS*†

DOBYNS, B. M. (1950) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-10-10-1202 · Cited by 57 · see citing works

Reevaluating Thyrotropin Receptor-Induced Mouse Models of Graves’ Disease and Ophthalmopathy

Baker, G. R. C., Mazziotti, G., von Ruhland, C., et al. (2004) · Endocrinology · doi:10.1210/en.2004-1015 · Cited by 54 · see citing works

Thyroid associated ophthalmopathy: evidence for CD4+ T cells; de novo differentiation of RFD7+ macrophages, but not of RFD1+ dendritic cells; and loss of and T cell receptor expression

Eckstein, A. K. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.035915 · Cited by 54 · see citing works

Relationship between Disease Duration and Predominant Orbital T Cell Subset in Graves' Ophthalmopathy

Aniszewski, J. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.776 · Cited by 54 · see citing works

Evidence for Enhanced Thy-1 (CD90) Expression in Orbital Fibroblasts of Patients with Graves' Ophthalmopathy

Khoo, T. K., Coenen, M. J., Schiefer, A. R., et al. (2008) · Thyroid · doi:10.1089/thy.2008.0255 · Cited by 53 · see citing works

TSH stimulates adipogenesis in mouse embryonic stem cells

Lu, M., & Lin, R.-Y. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0452 · Cited by 52 · see citing works

Thyrotropin interactions with human fat cell membrane preparations and the finding of a soluble thyrotropin binding component

Mullin, B. R., Lee, G., Ledley, F. D., et al. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(76)80271-9 · Cited by 49 · see citing works

Stimulation of Adipogenesis, Peroxisome Proliferator-Activated Receptor- (PPAR ), and Thyrotropin Receptor by PPAR Agonist in Human Orbital Preadipocyte Fibroblasts

Valyasevi, R. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2352 · Cited by 41 · see citing works

Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes

Dorkhan, M., Lantz, M., Frid, A. H., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02542.x · Cited by 36 · see citing works

Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens

Otto, E. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.3045 · Cited by 32 · see citing works

Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy

Tan, G. H. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.2.449 · Cited by 32 · see citing works

Presence of nonfunctional thyrotropin receptor variant transcripts in retroocular and other tissues

Paschke, R. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.5.1234 · Cited by 32 · see citing works

Attenuation of Induced Hyperthyroidism in Mice by Pretreatment with Thyrotropin Receptor Protein: Deviation of Thyroid-Stimulating to Nonfunctional Antibodies

Misharin, A. V., Nagayama, Y., Aliesky, H. A., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0181 · Cited by 27 · see citing works

Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expression

Cao, H., Han, R., & Smith, T. J. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00354.2002 · Cited by 26 · see citing works

Effect of Tumor Necrosis Factor- , Interferon- , and Transforming Growth Factor- on Adipogenesis and Expression of Thyrotropin Receptor in Human Orbital Preadipocyte Fibroblasts

Valyasevi, R. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.903 · Cited by 25 · see citing works

Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of Graves’ ophthalmopathy patients

KONUK, E. B. Y., Konuk, O., Mısırlıoğlu, M., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02280 · Cited by 22 · see citing works

Surgical management of ophthalmopathy in Graves' disease. Transfrontal orbital decompression.

Riley, F. C. (1972) · PubMed · Cited by 16 · see citing works

The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy

Smith, T. J. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212175 · Cited by 15 · see citing works

Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs

Cozma, I., Zhang, L., Uddin, J., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00177.2007 · Cited by 11 · see citing works

B-cell inhibitors as therapy for rheumatoid arthritis: An update

Kwan‐Morley, J., & Albert, D. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0064-4 · Cited by 10 · see citing works

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works

Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists

Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098 · see citing works

The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy Guidelines for the Management of Graves’ Orbitopathy

Bartalena, L., Baldeschi, L., Boboridis, K., Eckstein, A., Kahaly, G. J., Marcocci, C., Perros, P., Salvi, M., & Wiersinga, W. M. (2016) · European Thyroid Journal · doi:10.1159/000443828 · Cited by 943 · see citing works

Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists

The American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898 · see citing works

Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center

Tanda, M. L., Piantanida, E., Liparulo, L., Veronesi, G., Lai, A., Sassi, L., Pariani, N., Gallo, D., Azzolini, C., Ferrario, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3873 · Cited by 328 · see citing works

Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy

Min, L., Vaidya, A., & Becker, C. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0833 · Cited by 179 · see citing works

Incidence and Clinical Presentation of Moderate to Severe Graves' Orbitopathy in a Danish Population before and after Iodine Fortification of Salt

Laurberg, P., Berman, D. C., Bülow Pedersen, I., Andersen, S., & Carlé, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1275 · Cited by 133 · see citing works

The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy

Bartalena, L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2329 · Cited by 93 · see citing works

A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves’ orbitopathy

Wang, Y., Chen, Z., Wang, T., Guo, H., Liu, Y., Dang, N., Hu, S., Wu, L., Zhang, C., Ye, K., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00615-2 · Cited by 82 · see citing works

Thyroid-Like Ophthalmopathy in a Euthyroid Patient Receiving Ipilimumab

McElnea, E., Ní Mhéalóid, Á., Moran, S., Kelly, R., & Fulcher, T. (2014) · Orbit · doi:10.3109/01676830.2014.949792 · Cited by 93 · see citing works

A Small Molecule Antagonist Inhibits Thyrotropin Receptor Antibody-Induced Orbital Fibroblast Functions Involved in the Pathogenesis of Graves Ophthalmopathy

Turcu, A. F., Kumar, S., Neumann, S., Coenen, M., Iyer, S., Chiriboga, P., Gershengorn, M. C., & Bahn, R. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1149 · Cited by 84 · see citing works

The American Thyroid Association/American Association of Clinical Endocrinologists Guidelines for Hyperthyroidism and Other Causes of Thyrotoxicosis: A European Perspective

Kahaly, G. J., Bartalena, L., & Hegedüs, L. (2011) · Thyroid® · doi:10.1089/thy.2011.2106.ed3 · Cited by 80 · see citing works

Significance of detecting TRAb in patients with Graves disease or Graves ophthalmopathy

Ji, S. (2011) · Jiangsu Medical Journal

The clinical value of serum thyrotrophin receptor antibody level in patients with Graves ophthalmopathy

Wang, C.-D., Shi, Y., & Yan, B. (2013) · Int J Radiat Med Nuel Med · doi:10.3760/cma.j.issn.1673-4114.2013.02.004

Practical Guidelines Management of Graves Ophthalmopathy.

Subekti, I., Soewondo, P., Soebardi, S., et al. (2019) · Acta medica Indonesiana · Cited by 15 · see citing works

How suitable is intravenous tocilizumab for the treatment of Graves’ ophthalmopathy?

González, M. A. M., & Carbone, J. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1997591 · Cited by 3 · see citing works

Effect of 131 I therapy on outcomes of Graves' ophthalmopathy

Wang, R., Jian, T., Zhang, G., et al. (2011) · doi:10.3760/cma.j.issn.1673-4114.2011.04.007